|
Pinkwashing
6 hours ago
by Grandfather Smiles
The CEO of The Susan G. Komen Foundation nonprofit has an annual salary of over $500,000 and the Vice President of Development made over $400,000 in just one half of a year... "The Komen Foundation owns stock in General Electric, one of the largest makers of mammogram machines in the world. It also ...
Grandfather Smiles - grandfathersmiles.blogspot.com
|
|
Merck Takes Down Propecia Site as Lawsuits Mount
2 days ago
by Laurie
Just as it is facing an increasing number of lawsuits over Propecia, its prescription drug to treat male pattern baldness, Merck & Co. recently pulled down its website for the drug. The development is fueling speculation in some quarters that … Continue reading →
NewsInferno - newsinferno.com
|
|
Cancer Patients Should be of Death Risk Associated with Nexavar, Sutent and ...
2 days ago
by Joshua
Three newer chemotherapy drugs used in the treatment of cancer may be linked to an increased risk of death. According to a HealthDay News report on a recently published study from Dana-Farber Cancer Institute, the newer drugs Nexavar (sorafenib, in … Continue reading →
NewsInferno - newsinferno.com
|
|
Stopping Bisphosphonates May Reduce Femur Fracture Risk
2 days ago
by Laurie
Stopping bisphosphonates, a class of osteoporosis drugs that builds bone, could reduce risks for femur fracture by half, according to growing research. The rare, but serious, thigh bone fracture, known as atypical femur fracture, has been linked to oral bisphosphonates … Continue reading →
NewsInferno - newsinferno.com
|
|
Akorn Stock Has Healthy Upside
// technology
2 days ago
by Zacks.com
[1]Another essential cog in the new health care machine will be the availability of low-cost generic medicine for common conditions and perhaps even more importantly for specialized niche care. It is extremely important to keep the production of critical drugs flowing into the hands of consumers in ...
Forbes Network Activity - blogs.forbes.com/network/rss
|
|
Pfizer Moves to Consolidate Zoloft Birth Defect Lawsuits
2 days ago
by Laurie
A growing number of Zoloft birth defect lawsuits have prompted Pfizer Inc., the maker of the drug, to request that all federal complaints be consolidated in a multidistrict litigation. Last month, the drug maker filed a motion with the U.S. … Continue reading →
NewsInferno - newsinferno.com
|
|
Aromasin May Cause Bone Loss, Study Finds
3 days ago
by Joshua
A new study linking the breast cancer prevention drug Aromasin (exemestane) to decreased bone density and bone loss has stunted optimism surrounding the drug. According to The New York Times, a study conducted last summer from University Health Network, Toronto, … Continue reading →
NewsInferno - newsinferno.com
|
|
Freebies leave one internist wanting something more--the truth
3 days ago
by Peter A. Lipson, MD
Once upon a time we used to let drug reps feed us, bring us tchotchkes, and generally use our time. The staff liked the free food, and our patients liked the free drug samples. But we didn't like how it made us feel. The pharmaceutical companies have stopped giving out pens and such, and we have sto ...
ACP Internist - blog.acpinternist.org
|
|
Louisiana Family Blames Zoloft for Child’s Birth Defects
3 days ago
by Laurie
A family in Louisiana has filed suit against Pfizer Inc. claiming the company’s antidepressant, Zoloft, was responsible for their child’s birth defects. In their Zoloft lawsuit, Terry and Nelda Rolling accuse Pfizer of failing to adequately warn of the drug’s … Continue reading →
NewsInferno - newsinferno.com
|
|
